The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings. [PDF]
Valeri V +7 more
europepmc +1 more source
Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children. [PDF]
Tang X +16 more
europepmc +1 more source
Efficacy, Immunogenicity, and Safety of Pertussis Vaccine During Pregnancy: A Meta-Analysis. [PDF]
Shi Q +8 more
europepmc +1 more source
Safety Evaluation of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) During Pregnancy Among Vietnamese Women. [PDF]
Nguyen HM, Tran NT, Pham QH, Cao HN.
europepmc +1 more source
Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back. [PDF]
Villar-Álvarez F +2 more
europepmc +1 more source
Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. [PDF]
Liu M +6 more
europepmc +1 more source
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]
Yount KS +11 more
europepmc +1 more source
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis. [PDF]
Ma L, Caulfield A, Dewan KK, Harvill ET.
europepmc +1 more source

